312 related articles for article (PubMed ID: 35518926)
1. Angiotensin and Endothelin Receptor Structures With Implications for Signaling Regulation and Pharmacological Targeting.
Speck D; Kleinau G; Szczepek M; Kwiatkowski D; Catar R; Philippe A; Scheerer P
Front Endocrinol (Lausanne); 2022; 13():880002. PubMed ID: 35518926
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against Angiotensin II Type 1 and Endothelin 1 Type A Receptors in Cardiovascular Pathologies.
Civieri G; Iop L; Tona F
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055116
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin receptor type 1 and endothelin receptor type A on immune cells mediate migration and the expression of IL-8 and CCL18 when stimulated by autoantibodies from systemic sclerosis patients.
Günther J; Kill A; Becker MO; Heidecke H; Rademacher J; Siegert E; Radić M; Burmester GR; Dragun D; Riemekasten G
Arthritis Res Ther; 2014 Mar; 16(2):R65. PubMed ID: 24612997
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies Targeting AT
Catar R; Herse-Naether M; Zhu N; Wagner P; Wischnewski O; Kusch A; Kamhieh-Milz J; Eisenreich A; Rauch U; Hegner B; Heidecke H; Kill A; Riemekasten G; Kleinau G; Scheerer P; Dragun D; Philippe A
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008670
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II enhances endothelin-1-induced vasoconstriction through upregulating endothelin type A receptor.
Lin YJ; Kwok CF; Juan CC; Hsu YP; Shih KC; Chen CC; Ho LT
Biochem Biophys Res Commun; 2014 Aug; 451(2):263-9. PubMed ID: 25088996
[TBL] [Abstract][Full Text] [Related]
6. Non-HLA antibodies targeting angiotensin II Type 1 receptor and endothelin-1 Type A receptors induce endothelial injury via β2-arrestin link to mTOR pathway.
Catar RA; Wischnewski O; Chen L; Heidecke H; Rutz C; Schülein R; Dragun D; Philippe A; Kusch A
Kidney Int; 2022 Mar; 101(3):498-509. PubMed ID: 34757123
[TBL] [Abstract][Full Text] [Related]
7. Monocytic Angiotensin and Endothelin Receptor Imbalance Modulate Secretion of the Profibrotic Chemokine Ligand 18.
Rademacher J; Kill A; Mattat K; Dragun D; Siegert E; Günther J; Riemekasten G
J Rheumatol; 2016 Mar; 43(3):587-91. PubMed ID: 26773103
[TBL] [Abstract][Full Text] [Related]
8. Endothelin receptor signaling: new insight into its regulatory mechanisms.
Horinouchi T; Terada K; Higashi T; Miwa S
J Pharmacol Sci; 2013; 123(2):85-101. PubMed ID: 24077109
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome.
El Band JEK; Llorente S; Martinez-Garcia P; Alfaro R; Jimenez-Coll V; Boix F; Galián JA; Martinez-Banaclocha H; Botella C; Moya-Quiles MR; Minguela A; Legaz I; Muro M
Curr Protein Pept Sci; 2021; 22(10):745-757. PubMed ID: 34967284
[TBL] [Abstract][Full Text] [Related]
10. Molecular Effects of Auto-Antibodies on Angiotensin II Type 1 Receptor Signaling and Cell Proliferation.
Philippe A; Kleinau G; Gruner JJ; Wu S; Postpieszala D; Speck D; Heidecke H; Dowell SJ; Riemekasten G; Hildebrand PW; Kamhieh-Milz J; Catar R; Szczepek M; Dragun D; Scheerer P
Int J Mol Sci; 2022 Apr; 23(7):. PubMed ID: 35409344
[TBL] [Abstract][Full Text] [Related]
11. Structural basis of peptide recognition and activation of endothelin receptors.
Ji Y; Duan J; Yuan Q; He X; Yang G; Zhu S; Wu K; Hu W; Gao T; Cheng X; Jiang H; Eric Xu H; Jiang Y
Nat Commun; 2023 Mar; 14(1):1268. PubMed ID: 36882417
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune activation and hypersensitization of the AT1 and ETA receptors contributes to vascular injury in scleroderma renal crisis.
Hegner B; Kretzschmar T; Zhu N; Kleinau G; Zhao H; Kamhieh-Milz J; Hilger J; Schindler R; Scheerer P; Riemekasten G; Philippe A; Catar R
Rheumatology (Oxford); 2023 Jun; 62(6):2284-2293. PubMed ID: 36227102
[TBL] [Abstract][Full Text] [Related]
13. RGS proteins and cardiovascular Angiotensin II Signaling: Novel opportunities for therapeutic targeting.
Lymperopoulos A; Borges JI; Stoicovy RA
Biochem Pharmacol; 2023 Dec; 218():115904. PubMed ID: 37922976
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis.
Kill A; Tabeling C; Undeutsch R; Kühl AA; Günther J; Radic M; Becker MO; Heidecke H; Worm M; Witzenrath M; Burmester GR; Dragun D; Riemekasten G
Arthritis Res Ther; 2014 Jan; 16(1):R29. PubMed ID: 24472528
[TBL] [Abstract][Full Text] [Related]
15. Novel mechanisms of G-protein-coupled receptors functions: AT
Tóth AD; Turu G; Hunyady L; Balla A
Best Pract Res Clin Endocrinol Metab; 2018 Apr; 32(2):69-82. PubMed ID: 29678287
[TBL] [Abstract][Full Text] [Related]
16. Adrenal angiotensin II type 1 receptor biased signaling: The case for "biased" inverse agonism for effective aldosterone suppression.
Ferraino KE; Cora N; Pollard CM; Sizova A; Maning J; Lymperopoulos A
Cell Signal; 2021 Jun; 82():109967. PubMed ID: 33640432
[TBL] [Abstract][Full Text] [Related]
17. Antibodies against angiotensin II receptor type 1 and endothelin A receptor are increased in COVID-19 patients.
Miedema JR; Janssen ML; von der Thüsen J; Endeman H; Langerak AW; Hellemons ME; van Nood E; Peeters BWA; Baart SJ; Schreurs MWJ
Front Immunol; 2023; 14():1204433. PubMed ID: 37622126
[TBL] [Abstract][Full Text] [Related]
18. Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis.
Budding K; van de Graaf EA; Hoefnagel T; Kwakkel-van Erp JM; van Kessel DA; Dragun D; Hack CE; Otten HG
J Cyst Fibros; 2015 Jan; 14(1):42-5. PubMed ID: 25096855
[TBL] [Abstract][Full Text] [Related]
19. When natural antibodies become pathogenic: autoantibodies targeted against G protein-coupled receptors in the pathogenesis of systemic sclerosis.
Akbarzadeh R; Müller A; Humrich JY; Riemekasten G
Front Immunol; 2023; 14():1213804. PubMed ID: 37359516
[TBL] [Abstract][Full Text] [Related]
20. Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors.
Bosnyak S; Jones ES; Christopoulos A; Aguilar MI; Thomas WG; Widdop RE
Clin Sci (Lond); 2011 Oct; 121(7):297-303. PubMed ID: 21542804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
